Εμφανίζονται 1 - 16 Αποτελέσματα από 16 για την αναζήτηση '"ТКАНЕВАЯ ОКСИМЕТРИЯ"', χρόνος αναζήτησης: 0,75δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Συνεισφορές: РФФИ, проект № 18-02-00564/18

    Πηγή: Biomedical Photonics; Том 8, № 1 (2019); 38-45 ; 2413-9432 ; 10.24931/2413-9432-2019-8-1

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.pdt-journal.com/jour/article/view/292/208; https://www.pdt-journal.com/jour/article/view/292/238; Wynn T.A., Ramalingam T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease //Nature medicine. – 2012. – Vol. 18. – №. 7. – P. 1028–1040.; Wynn T.A. Integrating mechanisms of pulmonary fibrosis // Journal of Experimental Medicine. – 2011. – Vol. 208. – No. 7. – P. 1339–1350.; Струков А.И., Серов В.В. Патологическая анатомия. 6-е изд. – М.: ГЭОТАР-Медиа, 2015. – С. 254–255.; Rockey D.C., Bell P.D., Hill J.A. Fibrosis–a common pathway to organ injury and failure //New England Journal of Medicine. – 2015. – Vol. 372. – No. 12. – P. 1138–1149.; Andrews J.P., Marttala J., Macarak E., et al. Keloids: The paradigm of skin fibrosis–Pathomechanisms and treatment //Matrix Biology. – 2016. – Vol. 51. – P. 37–46.; Bijlard E., Kouwenberg C.A., Timman R., et al. Burden of keloid disease: A cross-sectional health-related quality of life assessment //Acta dermato-venereologica. – 2017. – Vol. 97, No. 2. – P. 225–229.; Bock O., Schmid-Ott G., Malewski P., Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring //Archives of dermatological research. – 2006. – Vol. 297, No. 10. – P. 433.; Muangchan C., Harding S., Khimdas S., et al. Association of C‐ reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group // Arthritis Care Res (Hoboken). – 2012. – Vol. 64, No. 9. – P. 1405–1414.; Habiel D.M., Hogaboam C. Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis // Frontiers in pharmacology. – 2014. – Vol. 5, No. 2. – P. 1–6.; Wang W., Qu M., Xu L., et al. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways // J Mol Med (Berl). – 2016. – Vol. 94, No. 10. – P. 1181–1194.; Driskell R.R., Lichtenberger B.M., Hoste E., et al. Distinct fibroblast lineages determine dermal architecture in skin development and repair // Nature. – 2013. – Vol. 504. – P. 277–281.; Manresa M.C., Godson C., Taylor C.T. Hypoxia-sensitive pathways in inflammation-driven fibrosis // American Journal of PhysiologyRegulatory, Integrative and Comparative Physiology. – 2014. – Vol. 307, No. 12. – P. R1369-R1380.; Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ //The Journal of clinical investigation. – 2007. – Vol. 117, No. 3. – P. 539–548.; Lokmic Z., Musyoka J., Hewitson T.D., Darby I.A. Hypoxia and hypoxia signaling in tissue repair and fibrosis // Int Rev Cell Mol Biol. – 2012. – Vol. 296. – P. 139–185.; Гуллер А.Е., Шехтер А.Б. Клинический тип и гистологическая структура кожных рубцов как прогностические факторы исхода лечения // Анналы пластической, реконструктивной и эстетической хирургии. – 2007. – №. 4. – С. 19–31.; Monstrey S., Hoeksema H., Verbelen J., et al. Assessment of burn depth and burn wound healing potential // Burns. – 2008. – Vol. 34, No. 6. – P. 761–769.; Mustoe T.A., Cooter R.D., Gold M.H., et al. International Advisory Panel on Scar Management. International clinical recommendations on scar management // Plast Reconstr Surg. – 2002. – Vol. 110, No. 2. – P. 560–571.; Kang T., Abignano G., Lettieri G., et al. Skin imaging in systemic sclerosis // Eur J Rheumatol. – 2014. – Vol. 1, No. 3. – P. 111–116.; Smirnova O.D., Rogatkin D.A., Litvinova K.S. Collagen as in vivo quantitative fluorescent biomarkers of abnormal tissue changes // Journal of Innovative Optical Health Sciences. – 2012. – Vol. 5, No. 2. – P. 1250010.; Franco W., Gutierrez-Herrera E., Kollias N., Doukas A. Review of applications of fluorescence excitation spectroscopy to dermatology // Br J Dermatol. – 2016. – Vol. 174, No. 3. – P. 499–50 4 .; Avouac J. Mouse model of experimental dermal fibrosis: the bleomycin-induced dermal fibrosis // Methods Mol Biol. – 2014. – Vol. 1142. – P. 91–8.; Li Y., Zhang J., Zhang W., et al. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1 // J Mol Histol. – 2017. – Vol. 48, No. 5–6. – P. 357–366.; Rogatkin D.A., Lapaeva L.G., Petrinskaya E.N., et al. Multifunctional laser noninvasive spectroscopic system for medical diagnostics and metrological provisions for that // Proceedings of SPIE – The International Society for Optical Engineering. – 2009. DOI:10.1117/12.831602; Rogatkin D., Shumskiy V., Tereshenko S., Polyakov P. Laser-based non-invasive spectrophotometry – An overview of possible medical applications // Photon Lasers Med. – 2013. – Vol. 2, No. 3. – P. 225–240.; Ho Y.Y., Lagares D., Tager A.M., Kapoor M. Fibrosis–a lethal component of systemic sclerosis // Nat Rev Rheumatol. – 2014. – Vol. 10, No. 7. – P. 390–402.; Petritskaya E.N., Kulikov D.A., Rogatkin D.A., et al. Use of fluorescence spectroscopy for diagnosis of hypoxia and inflammatory processes in tissue // Journal of Optical Technology. – 2015. – Vol. 82, No. 12. – P. 810–814.; Van Hal T.W., van Bon L., Radstake T.A system out of breath: how hypoxia possibly contributes to the pathogenesis of systemic sclerosis // International Journal of Rheumatology. – 2011. – Vol. 2011. – P. 824-972; Darby I.A., Hewitson T.D. Hypoxia in tissue repair and fibrosis // Cell and tissue research. – 2016. – Vol. 365, No. 3. – P. 553–562.; Issa R., Zhou X., Constandinou C.M., et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking // Gastroenterology. – 2004. – Vol. 126, No. 7. – P. 1795–1808.; Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ // Journal of clinical investigation. – 2007. – Vol. 117, No. 3. – P. 539–548.

  2. 2
  3. 3
  4. 4
    Academic Journal
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16